Which bioequivalence study for a racemic drug? Application to milnacipran-Reference-Cited by-同舟云学术

Which bioequivalence study for a racemic drug? Application to milnacipran

Published:1998-06 Issue:2 Volume:23 Page:166-171
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:European Journal of Drug Metabolism and Pharmacokinetics

Author:

Deprez D.,Chassard D.,Baille P.,Mignot A.,Ung H. L.,Puozzo C.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF03189334.pdf

Reference9 articles.

1. Russel R.M., et al. (1984) ‘Reference weight. Practical considerations’. Am. J. Med. 76, 767–769.

2. Puozzo C, Duchene P, Bromet M, Filaquier C, Zorza G. (1996): Determination of milnacipran (F2207) and its glucuroconjugate in plasma, blood and urine by high performance liquid chromatography with fluorescence detection.J Chromatogr. To be published.

3. Ung HL, Briem S, Puozzo C. (1996) Enantioselective determination of the two enantiomers of milnacipran (F2207) in plasma and urine by gas chromatography-mass spectrometry.J Chromatogr. To be published.

4. Rowland M. Tozer, T.N., (1980) Clinical pharmacokinetics: Concepts and applications ed. Lea & Febinger, Philadelphia.

5. Steinijans V.W., Hauschke D. (1992) Controversies in bioequivalence studies. Clin. Pharmacokinet., 22 (4): 47–253.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic and Brain Pharmacokinetics of Milnacipran in Mice: Comparison of Intraperitoneal and Intravenous Administration;Pharmaceutics;2023-12-29

2. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants;The World Journal of Biological Psychiatry;2021-05-12

3. About the Misleading Use of Stereodescriptors in Labeling the Stereoisomers of Milnacipran and Levomilnacipran;Journal of Clinical Psychopharmacology;2019-10-31

4. Serotonin and Norepinephrine Reuptake Inhibitors;Antidepressants;2018

5. Disposition and metabolism of [14C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats;Drug Design, Development and Therapy;2015-06